NE

Neuraxis, INC

  • CIK: 0001933567
  • EIN: 45-5079684
  • Business address: 11550 N. MERIDIAN STREET, SUITE 325, CARMEL, Indiana, 46032

Information

  • Mailing address
    11550 N. MERIDIAN STREET, SUITE 325, CARMEL, Delaware, 46032
  • Phone
    (812) 689-0791
  • State location
    Indiana
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    3845 - (CF Office: Office of Life Sciences) ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
  • Filings
    N/A

About Neuraxis, INC

Neuraxis, INC (CIK: 0001933567) is an American company incorporated in the state of Indiana. Head office is located at 11550 N. MERIDIAN STREET, SUITE 325, CARMEL, Indiana, 46032. Work in the industry 3845 - (CF Office: Office of Life Sciences) ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS. Neuraxis, INC is a public company and trade via Over-The-Counter (OTC).

Ownership

Owner Filings Transaction Date Type of Owner
MASIMO CORP 0000937556 Aug-08-2023 10 percent owner
SEALE JOHN G 0001519647 Aug-08-2023 officer: CHIEF FINANCIAL OFFICER
Carrico Brian Allen 0001959279 Aug-08-2023 director, officer: CEO, DIRECTOR
Brown Christopher Robin 0001959280 Aug-08-2023 director, officer: DIRECTOR OF INNOVATION
Clarence Daniel Jerome 0001959284 Aug-08-2023 officer: CHIEF OPERATING OFFICER
Carrico Thomas Joeseph 0001959325 Aug-08-2023 officer: CHIEF REGULATORY OFFICER
Peterson Gary Merril 0001959525 Aug-08-2023 officer: DIR.OF DESIGN & ENGINEERING
Watkins Bradley Mitchell 0001959534 Aug-08-2023 director
Keyser Jane Elizabeth 0001959756 Aug-08-2023 director
Henrichs Timothy Robert 0001959954 Aug-08-2023 director
Miranda Adrian 0001992525 Aug-08-2023 officer: Chief Medical Officer, SVP

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Neuraxis, INC

Filings Format Description Filed/Effective File/Film Number
8-K Document

Current report filing

Acc-no: 0001493152-24-036212 (34 Act) Size: KB		 Sep-13-2024

001-41775

241298217
8-K Document

Current report filing

Acc-no: 0001493152-24-033444 (34 Act) Size: KB		 Aug-21-2024

001-41775

241228910
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001493152-24-030875 (34 Act) Size: KB		 Aug-09-2024

001-41775

241190468
8-K Document

Current report filing

Acc-no: 0001493152-24-030873 (34 Act) Size: KB		 Aug-09-2024

001-41775

241190462
8-K Document

Current report filing

Acc-no: 0001493152-24-026362 (34 Act) Size: KB		 Jul-05-2024

001-41775

241102810
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001493152-24-025972 ( Act) Size: 0 KB		 Jul-02-2024

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001493152-24-025970 ( Act) Size: 0 KB		 Jul-02-2024

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001493152-24-025968 ( Act) Size: 0 KB		 Jul-02-2024

ARS Document

Annual report to security holders

Acc-no: 0001493152-24-025807 (34 Act) Size: KB		 Jul-01-2024

001-41775

241091072
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0001140361-24-031948 (34 Act) Size: KB		 Jul-01-2024

001-41775

241090565
DEF 14A Document

Definitive proxy statements

Acc-no: 0001140361-24-031946 (34 Act) Size: KB		 Jul-01-2024

001-41775

241090536
PRE 14A Document

Preliminary proxy statement not related to a contested matter or merger/acquisition

Acc-no: 0001140361-24-030932 (34 Act) Size: KB		 Jun-21-2024

001-41775

241061399
8-K Document

Current report filing

Acc-no: 0001493152-24-021615 (34 Act) Size: KB		 May-28-2024

001-41775

24992023
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001493152-24-020692 (34 Act) Size: KB		 May-20-2024

001-41775

24964756
NT 10-Q Document

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Acc-no: 0001493152-24-019866 (34 Act) Size: KB		 May-15-2024

001-41775

24950935
10-K Document

Annual report pursuant to section 13 and 15(d)

Acc-no: 0001493152-24-014832 (34 Act) Size: KB		 Apr-16-2024

001-41775

24848232
8-K Document

Current report filing

Acc-no: 0001493152-24-014829 (34 Act) Size: KB		 Apr-16-2024

001-41775

24848188
8-K Document

Current report filing

Acc-no: 0001493152-24-014075 (34 Act) Size: KB		 Apr-09-2024

001-41775

24833057
NT 10-K Document

Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT

Acc-no: 0001493152-24-012344 (34 Act) Size: KB		 Apr-01-2024

001-41775

24809087
8-K Document

Current report filing

Acc-no: 0001493152-24-011761 (34 Act) Size: KB		 Mar-28-2024

001-41775

24799579

Recent 20 filings. View all Neuraxis, INC filings

Reviews

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Frequently Asked Questions

Tags:

  • Neuraxis, INC overview
  • Neuraxis, INC job
  • Neuraxis, INC stock
  • Neuraxis, INC ownership
  • Neuraxis, INC CEO
  • Neuraxis, INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Pheton Holdings Ltd
Update: Nov 02, 2023
CardieX Ltd
Update: Jul 26, 2023
PIXIE DUST TECHNOLOGIES, INC.
Update: Jun 08, 2023
Cortigent, Inc.
Update: Mar 21, 2023
ZOLL MEDICAL CORP
Update: Aug 26, 2022
ZEVEX INTERNATIONAL INC
Update: Aug 25, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 3096 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3659 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 2863 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 1494 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 3710 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 2515 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 3367 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 4063 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 2044 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by